Occupational Risk Reduction by Radiotoxin Chelation

Miller, Scott C.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA047659-09
• Application #: 2092683
• Study Section: Safety and Occupational Health Study Section (SOH)
• Project Start: 1988-03-15
• Project End: 1998-02-28
• Budget Start: 1996-03-01
• Budget End: 1998-02-28
• Support Year: 9
• Fiscal Year: 1996

Institution

• Name: University of Utah
• Department: Radiation-Diagnostic/Oncology
• Type: Schools of Medicine
• City: Salt Lake City
• State: UT
• Country: United States
• Zip Code: 84112

Publications

Liu, G; Bruenger, F W; Miller, S C et al. (1998) Molecular structure and biological and pharmacological properties of 3-hydroxy-2-methyl-1-(beta-D-ribofuranosyl or pyranosyl)-4-pyridinone: potential iron overload drugs for oral administration. Bioorg Med Chem Lett 8:3077-80

Lloyd, R D; Taylor, G N; Mays, C W (1998) 241Am removal by DTPA vs. occurrence of skeletal malignancy. Health Phys 75:640-5

Miller, S C; Bruenger, F W; Kuswik-Rabiega, G et al. (1993) Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium. J Pharmacol Exp Ther 267:548-54

Miller, S C; Bruenger, F W; Kuswik-Rabiega, G et al. (1992) Decorporation of plutonium by oral administration of a partially lipophilic polyaminocarboxylic acid. Health Phys 63:195-7

Bruenger, F W; Kuswik-Rabiega, G; Miller, S C (1992) Decorporation of aged americium deposits by oral administration of lipophilic polyamino carboxylic acids. J Med Chem 35:112-8